Are Indian pharma firms getting better in the eyes of the world? | Business Matters | The Hindu

The United States accounts for about a third of India's pharmaceutical exports. Despite this, over the past few years, we hadn't really received the attention of the US market; and when we have, our quality compliance standards have frequently fallen short.

But data for this calendar year so far shows us that we may at least be inching back up to pre-pandemic levels and those green shoots give hope to the industry.

In this episode, we will see a little bit of pharmacology as well as learn a bit about the industry.

Script and presentation: K. Bharat Kumar
Videography: Thamodharan Bharath
Production: Shibu Narayan
#pharma #pharmacology #pharmaceuticalindustry #usfda #anda #Indiapharmaceuticalindustry #api #drugsafety #indianpharmaceuticalcompanies #china #coughsyrup #indianapimarket #compliancestandards

Thank you for watching our video!

You can subscribe to our channel here: https://bit.ly/3c8Adi6

Visit https://www.thehindu.com/ for the latest updates, analysis, opinions, and more.

You can also download our apps:
Android: https://bit.ly/3nboBEi
iOs: https://apple.co/3EDCwt4

The Hindu is committed to keeping you up-to-date with information on the developments in India and the world. We promise to deliver quality journalism that stays away from vested interest and political propaganda. You can support us by subscribing to our digital offerings here: https://bit.ly/3emywiz

Follow us:
Twitter: Twitter: the_hindu
Instagram: Instagram: the_hindu

• #news_politics
• #pharma
• #pharmacology
• #industry
• #export
• #thehindu
• #businessmatters